active
ENTELLIGENCE Young Investigators Award
Offered by Actelion Pharmaceuticals
ENTELLIGENCE is a program designed for basic science, translational and clinical research in the field of cardiopulmonary medicine. The ENTELLIGENCE program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research (basic science, translational and clinical research) in the area of pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology and ultimately, to improve treatment for patients with pulmonary hypertension.
Key Details
Deadline Invalid Date
Award Amount USD 100 000
Duration 1
Frequency Annual
Eligible Applicant Country United States, Canada
Host Country United States, Canada
Years Since PhD NA
Mobility Rule No
Career Levels
Funding Purpose
Subjects / Fields
Additional Information
Comments The young investigator must have no more than 5 years of experience beyond his/her faculty appointment at the start of the award (as of July 1st of the award year), but must be at a rank less than Associate Professor.
Applicants must be a United States (US) citizen, a permanent US resident, a Canadian citizen, or permanent Canadian resident at time of LOI submission. Applicants with nonimmigrant visas are not eligible to apply
About the Funder
Actelion Pharmaceuticals Switzerland
Record Information
Last Verified 19 February 2026 by asntech
Last Updated May 2020
Source legacy-import